In a deal valued at up to $1 billion, Roche has licensed rights to a DLL3-directed antibody-drug conjugate (ADC) from China's ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase ...

Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo. 2. In ...

INR:6144. south africa vs new zealand cricket live streaming free Hengrui Medicine's SHR-1707 approved for clinical trial ...

INR:3777. blind cricket 『Pharmaceutical Headlines』 Liaoning Province cancels village-level vaccination sites, Amgen lays off another 172 employees Another 21 li ...

INR:9367. birthday of virat kohli Huazhong Pharmaceutical's "Ambroxol Hydrochloride Injection" was approved as the second company to pass the consistency ...

ESMO | Olaparib and Imfinzi show promising long-term efficacy in treating ovarian cancer and lung cancer 20 Chinese patent medicines are amazing! 9 exclusive Chinese patent medicines lead the way with ...

tv shows with ma dong-seok "Pharmaceutical Speed Reading Club" Jiyao Holdings' net profit in 2019 is expected to be a loss of 1.5 billion Cellular nanoporation to generate functional exosomes as a new ...

INR:0165. anclent song by anthony brown GSK's three vaccine musketeers appeared at the third CIIE to discuss the value of vaccines in the post-epide ...

INR:4355. icc tournament schedule ESMO \| Olaparib and Imfinzi show promising long-term efficacy in treating ovarian cancer and lung cancer Mallinckrodt fi ...

INR:3185. rummy photos The 2019 version of the medical insurance catalogue is expected to be announced in early August, and a number of "safe and ineffective" drugs ...